Vaxess Technologies
VerifiedEngages in developing biomedical innovations with a focus on improving access to vaccines.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$135m (Public information from May 2024)
Cambridge Massachusetts (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor | $0.0 | round |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor investor investor investor | $0.0 | round | |
| investor investor investor | $0.0 Valuation: $0.0 | round | |
* | $12.0m Valuation: $135m | Late VC | |
| Total Funding | 000k | ||
Related Content
Recent News about Vaxess Technologies
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.